These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27262440)

  • 1. Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans.
    Sowada N; Stiller B; Kubisch C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):528-533. PubMed ID: 27262440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast.
    Huang Y; Chen X; He X; Guo C; Sun X; Liang F; Long S; Lu X; Feng L; Guo W; Zeng Y; Pei Z
    Mol Med Rep; 2017 Jul; 16(1):254-262. PubMed ID: 28487947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.
    McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ
    Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
    Chen X; Tsika E; Levine N; Moore DJ
    Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
    Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
    Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases.
    Follett J; Bugarcic A; Collins BM; Teasdale RD
    Curr Protein Pept Sci; 2017; 18(7):687-701. PubMed ID: 26965691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces α-Synuclein Aggregation.
    Follett J; Bugarcic A; Yang Z; Ariotti N; Norwood SJ; Collins BM; Parton RG; Teasdale RD
    J Biol Chem; 2016 Aug; 291(35):18283-98. PubMed ID: 27385586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease-linked
    Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPS35, the Retromer Complex and Parkinson's Disease.
    Williams ET; Chen X; Moore DJ
    J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.
    Tsika E; Glauser L; Moser R; Fiser A; Daniel G; Sheerin UM; Lees A; Troncoso JC; Lewis PA; Bandopadhyay R; Schneider BL; Moore DJ
    Hum Mol Genet; 2014 Sep; 23(17):4621-38. PubMed ID: 24740878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
    Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
    J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPS35 and retromer dysfunction in Parkinson's disease.
    Rowlands J; Moore DJ
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
    Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
    Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
    Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
    Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin.
    Malik BR; Godena VK; Whitworth AJ
    Hum Mol Genet; 2015 Nov; 24(21):6106-17. PubMed ID: 26251041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2.
    Yun SP; Kim H; Ham S; Kwon SH; Lee GH; Shin JH; Lee SH; Ko HS; Lee Y
    Cell Death Dis; 2017 Apr; 8(4):e2741. PubMed ID: 28383562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant-negative behavior of mammalian Vps35 in yeast requires a conserved PRLYL motif involved in retromer assembly.
    Zhao X; Nothwehr S; Lara-Lemus R; Zhang BY; Peter H; Arvan P
    Traffic; 2007 Dec; 8(12):1829-1840. PubMed ID: 17916227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.
    Dhungel N; Eleuteri S; Li LB; Kramer NJ; Chartron JW; Spencer B; Kosberg K; Fields JA; Stafa K; Adame A; Lashuel H; Frydman J; Shen K; Masliah E; Gitler AD
    Neuron; 2015 Jan; 85(1):76-87. PubMed ID: 25533483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
    Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
    Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of VPS35 in the Pathobiology of Parkinson's Disease.
    Sassone J; Reale C; Dati G; Regoni M; Pellecchia MT; Garavaglia B
    Cell Mol Neurobiol; 2021 Mar; 41(2):199-227. PubMed ID: 32323152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.